Dementia

Dementia Pharmaceuticals Clinical Trials Clinical Research Neurology Public Health Medical Research Cognitive Health Preventive Medicine Patient Care

4 ARTICLES

last wk.

Australia Approves Donanemab as First Disease-Modifying Alzheimer’s Therapy

The TGA has approved the groundbreaking drug for early-stage Alzheimer’s patients, offering hope for slowing cognitive decline, though high costs and safety protocols limit access.

8 ARTICLES

2w ago

Scott Mitchell Defends Relationship with Tanya Franks While Advocating for Dementia Awareness

4 ARTICLES

3w ago

New Data Confirms Low Risk of Severe Side Effects for Alzheimer’s Drug Lecanemab

9 ARTICLES

last mo.

Study Finds Digital Technology Use Reduces Cognitive Decline in Older Adults

8 ARTICLES

2mo ago

Study Suggests Long-Term Anti-Amyloid Therapy May Delay Early-Onset Alzheimer’s

7 ARTICLES

4mo ago

Study Links Common Medications to Reduced Dementia Risk